1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Monoclonal Antibody Therapeutics Market Size Growth Rate by Type: 2020 VS 2026 1.2.2 Humanized Antibody 1.2.3 Human Mouse Chimeric Antibody 1.3 Market by Application 1.3.1 Global Monoclonal Antibody Therapeutics Market Share by Application: 2020 VS 2026 1.3.2 Cancer 1.3.3 Autoimmune Diseases 1.3.4 Infection 1.3.5 Hematological Diseases 1.3.6 Ophthalmological Diseases 1.3.7 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Monoclonal Antibody Therapeutics Market Perspective (2015-2026) 2.2 Global Monoclonal Antibody Therapeutics Growth Trends by Regions 2.2.1 Monoclonal Antibody Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Monoclonal Antibody Therapeutics Historic Market Share by Regions (2015-2020) 2.2.3 Monoclonal Antibody Therapeutics Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Monoclonal Antibody Therapeutics Players by Market Size 3.1.1 Global Top Monoclonal Antibody Therapeutics Players by Revenue (2015-2020) 3.1.2 Global Monoclonal Antibody Therapeutics Revenue Market Share by Players (2015-2020) 3.2 Global Monoclonal Antibody Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Monoclonal Antibody Therapeutics Revenue 3.4 Global Monoclonal Antibody Therapeutics Market Concentration Ratio 3.4.1 Global Monoclonal Antibody Therapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Monoclonal Antibody Therapeutics Revenue in 2019 3.5 Key Players Monoclonal Antibody Therapeutics Area Served 3.6 Key Players Monoclonal Antibody Therapeutics Product Solution and Service 3.7 Date of Enter into Monoclonal Antibody Therapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Monoclonal Antibody Therapeutics Breakdown Data by Type (2015-2026) 4.1 Global Monoclonal Antibody Therapeutics Historic Market Size by Type (2015-2020) 4.2 Global Monoclonal Antibody Therapeutics Forecasted Market Size by Type (2021-2026) 5 Monoclonal Antibody Therapeutics Breakdown Data by Application (2015-2026) 5.1 Global Monoclonal Antibody Therapeutics Historic Market Size by Application (2015-2020) 5.2 Global Monoclonal Antibody Therapeutics Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Monoclonal Antibody Therapeutics Market Size (2015-2026) 6.2 North America Monoclonal Antibody Therapeutics Market Size by Type (2015-2020) 6.3 North America Monoclonal Antibody Therapeutics Market Size by Application (2015-2020) 6.4 North America Monoclonal Antibody Therapeutics Market Size by Country (2015-2020) 6.4.1 United States 6.4.2 Canada 7 Europe 7.1 Europe Monoclonal Antibody Therapeutics Market Size (2015-2026) 7.2 Europe Monoclonal Antibody Therapeutics Market Size by Type (2015-2020) 7.3 Europe Monoclonal Antibody Therapeutics Market Size by Application (2015-2020) 7.4 Europe Monoclonal Antibody Therapeutics Market Size by Country (2015-2020) 7.4.1 Germany 7.4.2 France 7.4.3 U.K. 7.4.4 Italy 7.4.5 Russia 7.4.6 Nordic 7.4.7 Rest of Europe 8 China 8.1 China Monoclonal Antibody Therapeutics Market Size (2015-2026) 8.2 China Monoclonal Antibody Therapeutics Market Size by Type (2015-2020) 8.3 China Monoclonal Antibody Therapeutics Market Size by Application (2015-2020) 8.4 China Monoclonal Antibody Therapeutics Market Size by Region (2015-2020) 8.4.1 China 8.4.2 Japan 8.4.3 South Korea 8.4.4 Southeast Asia 8.4.5 India 8.4.6 Australia 8.4.7 Rest of Asia-Pacific 9 Japan 9.1 Japan Monoclonal Antibody Therapeutics Market Size (2015-2026) 9.2 Japan Monoclonal Antibody Therapeutics Market Size by Type (2015-2020) 9.3 Japan Monoclonal Antibody Therapeutics Market Size by Application (2015-2020) 9.4 Japan Monoclonal Antibody Therapeutics Market Size by Country (2015-2020) 9.4.1 Mexico 9.4.2 Brazil 10 Southeast Asia 10.1 Southeast Asia Monoclonal Antibody Therapeutics Market Size (2015-2026) 10.2 Southeast Asia Monoclonal Antibody Therapeutics Market Size by Type (2015-2020) 10.3 Southeast Asia Monoclonal Antibody Therapeutics Market Size by Application (2015-2020) 10.4 Southeast Asia Monoclonal Antibody Therapeutics Market Size by Country (2015-2020) 10.4.1 Turkey 10.4.2 Saudi Arabia 10.4.3 UAE 10.4.4 Rest of Middle East & Africa 11 Key Players Profiles 11.1 Bayer 11.1.1 Bayer Company Details 11.1.2 Bayer Business Overview 11.1.3 Bayer Monoclonal Antibody Therapeutics Introduction 11.1.4 Bayer Revenue in Monoclonal Antibody Therapeutics Business (2015-2020)) 11.1.5 Bayer Recent Development 11.2 F. Hoffmann-La Roche 11.2.1 F. Hoffmann-La Roche Company Details 11.2.2 F. Hoffmann-La Roche Business Overview 11.2.3 F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Introduction 11.2.4 F. Hoffmann-La Roche Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) 11.2.5 F. Hoffmann-La Roche Recent Development 11.3 Pfizer 11.3.1 Pfizer Company Details 11.3.2 Pfizer Business Overview 11.3.3 Pfizer Monoclonal Antibody Therapeutics Introduction 11.3.4 Pfizer Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) 11.3.5 Pfizer Recent Development 11.4 Sanofi 11.4.1 Sanofi Company Details 11.4.2 Sanofi Business Overview 11.4.3 Sanofi Monoclonal Antibody Therapeutics Introduction 11.4.4 Sanofi Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) 11.4.5 Sanofi Recent Development 11.5 GlaxoSmithKline 11.5.1 GlaxoSmithKline Company Details 11.5.2 GlaxoSmithKline Business Overview 11.5.3 GlaxoSmithKline Monoclonal Antibody Therapeutics Introduction 11.5.4 GlaxoSmithKline Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) 11.5.5 GlaxoSmithKline Recent Development 11.6 Merck 11.6.1 Merck Company Details 11.6.2 Merck Business Overview 11.6.3 Merck Monoclonal Antibody Therapeutics Introduction 11.6.4 Merck Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) 11.6.5 Merck Recent Development 11.7 Novartis 11.7.1 Novartis Company Details 11.7.2 Novartis Business Overview 11.7.3 Novartis Monoclonal Antibody Therapeutics Introduction 11.7.4 Novartis Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) 11.7.5 Novartis Recent Development 11.8 AbbVie 11.8.1 AbbVie Company Details 11.8.2 AbbVie Business Overview 11.8.3 AbbVie Monoclonal Antibody Therapeutics Introduction 11.8.4 AbbVie Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) 11.8.5 AbbVie Recent Development 11.9 Amgen 11.9.1 Amgen Company Details 11.9.2 Amgen Business Overview 11.9.3 Amgen Monoclonal Antibody Therapeutics Introduction 11.9.4 Amgen Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) 11.9.5 Amgen Recent Development 11.10 Johnson & Johnson 11.10.1 Johnson & Johnson Company Details 11.10.2 Johnson & Johnson Business Overview 11.10.3 Johnson & Johnson Monoclonal Antibody Therapeutics Introduction 11.10.4 Johnson & Johnson Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) 11.10.5 Johnson & Johnson Recent Development 11.11 Bristol-Myers Squibb Company 10.11.1 Bristol-Myers Squibb Company Company Details 10.11.2 Bristol-Myers Squibb Company Business Overview 10.11.3 Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Introduction 10.11.4 Bristol-Myers Squibb Company Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) 10.11.5 Bristol-Myers Squibb Company Recent Development 11.12 Biogen 10.12.1 Biogen Company Details 10.12.2 Biogen Business Overview 10.12.3 Biogen Monoclonal Antibody Therapeutics Introduction 10.12.4 Biogen Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) 10.12.5 Biogen Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Monoclonal Antibody Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 3. Key Players of Humanized Antibody Table 4. Key Players of Human Mouse Chimeric Antibody Table 5. Global Monoclonal Antibody Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 6. Global Monoclonal Antibody Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026 Table 7. Global Monoclonal Antibody Therapeutics Market Size by Regions (2015-2020) (US$ Million) Table 8. Global Monoclonal Antibody Therapeutics Market Share by Regions (2015-2020) Table 9. Global Monoclonal Antibody Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 10. Global Monoclonal Antibody Therapeutics Market Share by Regions (2021-2026) Table 11. Monoclonal Antibody Therapeutics Market Market Trends Table 12. Monoclonal Antibody Therapeutics Market Drivers Table 13. Monoclonal Antibody Therapeutics Market Challenges Table 14. Monoclonal Antibody Therapeutics Market Restraints Table 15. Global Monoclonal Antibody Therapeutics Revenue by Players (2015-2020) (US$ Million) Table 16. Global Monoclonal Antibody Therapeutics Market Share by Players (2015-2020) Table 17. Global Top Monoclonal Antibody Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Antibody Therapeutics as of 2019) Table 18. Global Monoclonal Antibody Therapeutics by Players Market Concentration Ratio (CR5 and HHI) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Monoclonal Antibody Therapeutics Product Solution and Service Table 21. Mergers & Acquisitions, Expansion Plans Table 22. Global Monoclonal Antibody Therapeutics Market Size by Type (2015-2020) (US$ Million) Table 23. Global Monoclonal Antibody Therapeutics Market Size Share by Type (2015-2020) Table 24. Global Monoclonal Antibody Therapeutics Revenue Market Share by Type (2021-2026) Table 25. Global Monoclonal Antibody Therapeutics Market Size Share by Application (2015-2020) Table 26. Global Monoclonal Antibody Therapeutics Market Size by Application (2015-2020) (US$ Million) Table 27. Global Monoclonal Antibody Therapeutics Market Size Share by Application (2021-2026) Table 28. North America Monoclonal Antibody Therapeutics Market Size by Type (2015-2020) (US$ Million) Table 29. North America Monoclonal Antibody Therapeutics Market Share by Type (2015-2020) Table 30. North America Monoclonal Antibody Therapeutics Market Size by Application (2015-2020) (US$ Million) Table 31. North America Monoclonal Antibody Therapeutics Market Share by Application (2015-2020) Table 32. North America Monoclonal Antibody Therapeutics Market Size by Country (US$ Million) (2015-2020) Table 33. North America Monoclonal Antibody Therapeutics Market Share by Country (2015-2020) Table 34. Europe Monoclonal Antibody Therapeutics Market Size by Type (2015-2020) (US$ Million) Table 35. Europe Monoclonal Antibody Therapeutics Market Share by Type (2015-2020) Table 36. Europe Monoclonal Antibody Therapeutics Market Size by Application (2015-2020) (US$ Million) Table 37. Europe Monoclonal Antibody Therapeutics Market Share by Application (2015-2020) Table 38. Europe Monoclonal Antibody Therapeutics Market Size by Country (US$ Million) (2015-2020) Table 39. Europe Monoclonal Antibody Therapeutics Market Share by Country (2015-2020) Table 40. China Monoclonal Antibody Therapeutics Market Size by Type (2015-2020) (US$ Million) Table 41. China Monoclonal Antibody Therapeutics Market Share by Type (2015-2020) Table 42. China Monoclonal Antibody Therapeutics Market Size by Application (2015-2020) (US$ Million) Table 43. China Monoclonal Antibody Therapeutics Market Share by Application (2015-2020) Table 44. China Monoclonal Antibody Therapeutics Market Size by Region (US$ Million) (2015-2020) Table 45. China Monoclonal Antibody Therapeutics Market Share by Region (2015-2020) Table 46. Japan Monoclonal Antibody Therapeutics Market Size by Type (2015-2020) (US$ Million) Table 47. Japan Monoclonal Antibody Therapeutics Market Share by Type (2015-2020) Table 48. Japan Monoclonal Antibody Therapeutics Market Size by Application (2015-2020) (US$ Million) Table 49. Japan Monoclonal Antibody Therapeutics Market Share by Application (2015-2020) Table 50. Japan Monoclonal Antibody Therapeutics Market Size by Country (US$ Million) (2015-2020) Table 51. Japan Monoclonal Antibody Therapeutics Market Share by Country (2015-2020) Table 52. Southeast Asia Monoclonal Antibody Therapeutics Market Size by Type (2015-2020) (US$ Million) Table 53. Southeast Asia Monoclonal Antibody Therapeutics Market Share by Type (2015-2020) Table 54. Southeast Asia Monoclonal Antibody Therapeutics Market Size by Application (2015-2020) (US$ Million) Table 55. Southeast Asia Monoclonal Antibody Therapeutics Market Share by Application (2015-2020) Table 56. Southeast Asia Monoclonal Antibody Therapeutics Market Size by Country (US$ Million) (2015-2020) Table 57. Southeast Asia Monoclonal Antibody Therapeutics Market Share by Country (2015-2020) Table 58. Bayer Company Details Table 59. Bayer Business Overview Table 60. Bayer Product Table 61. Bayer Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (US$ Million) Table 62. Bayer Recent Development Table 63. F. Hoffmann-La Roche Company Details Table 64. F. Hoffmann-La Roche Business Overview Table 65. F. Hoffmann-La Roche Product Table 66. F. Hoffmann-La Roche Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (US$ Million) Table 67. F. Hoffmann-La Roche Recent Development Table 68. Pfizer Company Details Table 69. Pfizer Business Overview Table 70. Pfizer Product Table 71. Pfizer Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (US$ Million) Table 72. Pfizer Recent Development Table 73. Sanofi Company Details Table 74. Sanofi Business Overview Table 75. Sanofi Product Table 76. Sanofi Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (US$ Million) Table 77. Sanofi Recent Development Table 78. GlaxoSmithKline Company Details Table 79. GlaxoSmithKline Business Overview Table 80. GlaxoSmithKline Product Table 81. GlaxoSmithKline Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (US$ Million) Table 82. GlaxoSmithKline Recent Development Table 83. Merck Company Details Table 84. Merck Business Overview Table 85. Merck Product Table 86. Merck Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (US$ Million) Table 87. Merck Recent Development Table 88. Novartis Company Details Table 89. Novartis Business Overview Table 90. Novartis Product Table 91. Novartis Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (US$ Million) Table 92. Novartis Recent Development Table 93. AbbVie Business Overview Table 94. AbbVie Product Table 95. AbbVie Company Details Table 96. AbbVie Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (US$ Million) Table 97. AbbVie Recent Development Table 98. Amgen Company Details Table 99. Amgen Business Overview Table 100. Amgen Product Table 101. Amgen Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (US$ Million) Table 102. Amgen Recent Development Table 103. Johnson & Johnson Company Details Table 104. Johnson & Johnson Business Overview Table 105. Johnson & Johnson Product Table 106. Johnson & Johnson Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (US$ Million) Table 107. Johnson & Johnson Recent Development Table 108. Bristol-Myers Squibb Company Company Details Table 109. Bristol-Myers Squibb Company Business Overview Table 110. Bristol-Myers Squibb Company Product Table 111. Bristol-Myers Squibb Company Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (US$ Million) Table 112. Bristol-Myers Squibb Company Recent Development Table 113. Biogen Company Details Table 114. Biogen Business Overview Table 115. Biogen Product Table 116. Biogen Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (US$ Million) Table 117. Biogen Recent Development Table 118. Research Programs/Design for This Report Table 119. Key Data Information from Secondary Sources Table 120. Key Data Information from Primary Sources List of Figures Figure 1. Global Monoclonal Antibody Therapeutics Market Share by Type: 2020 VS 2026 Figure 2. Humanized Antibody Features Figure 3. Human Mouse Chimeric Antibody Features Figure 4. Global Monoclonal Antibody Therapeutics Market Share by Application: 2020 VS 2026 Figure 5. Cancer Case Studies Figure 6. Autoimmune Diseases Case Studies Figure 7. Infection Case Studies Figure 8. Hematological Diseases Case Studies Figure 9. Ophthalmological Diseases Case Studies Figure 10. Others Case Studies Figure 11. Monoclonal Antibody Therapeutics Report Years Considered Figure 12. Global Monoclonal Antibody Therapeutics Market Size (US$ Million), YoY Growth 2015-2026 Figure 13. Global Monoclonal Antibody Therapeutics Market Share by Regions: 2020 VS 2026 Figure 14. Global Monoclonal Antibody Therapeutics Market Share by Regions (2021-2026) Figure 15. Global Monoclonal Antibody Therapeutics Market Share by Players in 2019 Figure 16. Global Top Monoclonal Antibody Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Antibody Therapeutics as of 2019 Figure 17. The Top 10 and 5 Players Market Share by Monoclonal Antibody Therapeutics Revenue in 2019 Figure 18. North America Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 19. United States Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 20. Canada Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 21. Europe Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 22. Germany Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 23. France Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 24. U.K. Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 25. Italy Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 26. Russia Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 27. Nordic Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 28. Rest of Europe Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 29. Asia-Pacific Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 30. China Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 31. Japan Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 32. South Korea Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 33. Southeast Asia Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 34. India Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 35. Australia Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 36. Rest of Asia-Pacific Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 37. Latin America Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 38. Mexico Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 39. Brazil Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 40. Middle East & Africa Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 41. Turkey Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 42. Saudi Arabia Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 43. UAE Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 44. Rest of Middle East & Africa Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 45. Bayer Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020) Figure 46. F. Hoffmann-La Roche Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020) Figure 47. Pfizer Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020) Figure 48. Sanofi Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020) Figure 49. GlaxoSmithKline Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020) Figure 50. Merck Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020) Figure 51. Novartis Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020) Figure 52. AbbVie Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020) Figure 53. Amgen Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020) Figure 54. Johnson & Johnson Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020) Figure 55. Bristol-Myers Squibb Company Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020) Figure 56. Biogen Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020) Figure 57. Bottom-up and Top-down Approaches for This Report Figure 58. Data Triangulation Figure 59. Key Executives Interviewed

Bayer F. Hoffmann-La Roche Pfizer Sanofi GlaxoSmithKline Merck Novartis AbbVie Amgen Johnson & Johnson Bristol-Myers Squibb Company Biogen